Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Bosnia and Herzegovina

Bosnia and Herzegovina

The revenue in the Other Vaccines market in Bosnia and Herzegovina is estimated to reach US$7.02m in 2024.
It is expected to display an annual growth rate (CAGR 2024-2028) of 9.30%, leading to a market volume of US$10.02m by 2028.
When compared globally, United States is projected to generate the highest revenue, amounting to US$23,850.00m in 2024.
Bosnia and Herzegovina's market for other vaccines is experiencing a rising demand due to increased awareness about the importance of preventive healthcare measures.

Key regions: United Kingdom, China, Europe, India, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Bosnia and Herzegovina is experiencing steady growth in recent years.

Customer preferences: Bosnia and Herzegovina has a high vaccination rate, with a majority of the population being aware of the importance of vaccines. The demand for Other Vaccines is also increasing due to the rise in awareness about the prevention of infectious diseases.

Trends in the market: The Other Vaccines market in Bosnia and Herzegovina is expected to grow due to the increasing prevalence of infectious diseases. The market is also driven by the government's efforts to promote vaccination programs and initiatives. The market is expected to witness an increase in demand for vaccines for diseases such as typhoid, meningococcal, and hepatitis A and B.

Local special circumstances: Bosnia and Herzegovina has a well-established healthcare system that provides free vaccinations to the population. The country has a high incidence of infectious diseases, which has led to an increase in the demand for vaccines. Additionally, the country has a high incidence of travel-related diseases, which has led to an increase in demand for travel vaccines.

Underlying macroeconomic factors: The growth of the Other Vaccines market in Bosnia and Herzegovina is driven by the government's efforts to promote vaccination programs and initiatives. The country's healthcare system is well-established, and the government provides free vaccinations to the population. The increasing prevalence of infectious diseases and the high incidence of travel-related diseases are also driving the growth of the market. The country's stable economic conditions and increasing healthcare expenditure are expected to further boost the growth of the Other Vaccines market in Bosnia and Herzegovina.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.